Mestinon
Mestinon Price range: $ 64,00 through $ 403,00
Back to products
Methotrexate
Methotrexate Price range: $ 36,00 through $ 694,00

Metformin

Price range: $ 33,00 through $ 190,00

Metformin is a highly effective medication primarily used to manage and treat high blood sugar levels in individuals with type 2 diabetes. It works by decreasing the amount of glucose produced by the liver while increasing the body’s natural sensitivity to insulin. Regular use of this medication helps maintain stable blood sugar levels and can assist in preventing long-term health complications associated with diabetes. Most users find that Metformin is a reliable foundation for their daily treatment plan when combined with a balanced diet and regular exercise. This medication is available in various strengths and formulations, including immediate-release and extended-release tablets, to suit specific metabolic needs.

Active substance: metformin
SKU: Metformin Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Metformin belongs to a class of oral antihyperglycemic medications known as biguanides. It is an FDA-approved prescription drug primarily indicated to improve glycemic control in patients with type 2 diabetes mellitus.

In the United States, metformin is dispensed strictly in accordance with federal and state prescription regulations. It serves as a foundational pharmacotherapeutic option and is routinely prescribed in conjunction with dietary modifications and exercise regimens.

Parameter Specification
Active Ingredient Metformin hydrochloride
Therapeutic Class Biguanide antihyperglycemic agent
Dosage Form Oral tablet (immediate-release), oral extended-release tablet, oral solution
Route of Administration Oral
Primary Purpose Glycemic control in type 2 diabetes mellitus
Prescription Status Prescription (Rx) only
Storage Conditions Store at 68°F to 77°F (20°C to 25°C); excursions permitted between 59°F and 86°F (15°C and 30°C)

Overview and Medical Use

How the Drug Works

The mechanism of action of metformin involves three distinct pathways to lower blood glucose levels without stimulating endogenous insulin secretion. First, it reduces hepatic gluconeogenesis, thereby decreasing the amount of glucose produced by the liver. Second, it decreases intestinal absorption of glucose. Third, it increases peripheral insulin sensitivity by enhancing muscle tissue uptake and utilization of circulating glucose. Because metformin does not induce insulin secretion from pancreatic beta cells, monotherapy with this agent is generally not associated with hypoglycemia.

Main Uses

Metformin is FDA-approved for the management of type 2 diabetes mellitus as an adjunct to diet and exercise. Immediate-release formulations are indicated for adult patients and pediatric patients aged 10 years and older. Extended-release formulations are approved exclusively for adult patients. Off-label indications–uses not explicitly approved by the FDA but documented in clinical research–include polycystic ovary syndrome (PCOS) to assist with insulin resistance and cycle regularity, as well as prevention of type 2 diabetes in individuals identified with prediabetes. Off-label administration must be evaluated strictly on an individual basis by a qualified healthcare professional.

Dosing Schedule

Dosage must be individualized based on clinical response and laboratory monitoring of blood glucose and glycated hemoglobin (HbA1c). For immediate-release tablets, the starting dose is typically 500 mg twice daily or 850 mg once daily, administered with meals. The dose may be titrated in increments of 500 mg or 850 mg weekly or biweekly up to a maximum recommended dose of 2550 mg per day. Extended-release tablets are usually initiated at 500 mg or 1000 mg once daily with the evening meal, up to a maximum dose of 2000 mg daily. Dosage adjustments are mandatory in patients with renal impairment based on estimated glomerular filtration rate (eGFR) assessment.

What Happens in the Body

Following oral administration of an immediate-release tablet under fasting conditions, absolute bioavailability is approximately 50% to 60%. Peak plasma concentrations (Cmax) are attained within 2 to 3 hours for immediate-release forms and between 4 to 8 hours for extended-release formulations. Co-administration with food slightly delays absorption and decreases the peak plasma concentration. Metformin exhibits minimal binding to plasma proteins and partitions significantly into erythrocytes. The drug is not metabolized by the liver and undergoes no biliary excretion; it is eliminated unchanged in the urine via renal tubular secretion. The elimination half-life in plasma is approximately 6.2 hours, whereas the biological elimination half-life in blood is estimated at 17.6 hours due to red blood cell binding.

First Days of Treatment

During the initial days of therapy, gastrointestinal adaptations are frequently observed. Patients starting metformin may notice transient changes in bowel habits, mild abdominal discomfort, or nausea. These initial symptoms usually diminish within a few weeks as the gastrointestinal tract adjusts to the medication. Titrating the dosage gradually under medical supervision and consistently consuming the dose alongside meals helps mitigate initial gastrointestinal intolerance.

Safety, Side Effects, and Guidelines

What Not to Combine

Metformin exhibits critical drug-drug interactions that require clinical oversight. Concomitant administration of iodinated contrast media during radiological procedures increases the risk of acute renal failure and secondary lactic acidosis; metformin therapy must be temporarily discontinued prior to or at the time of such procedures. Cationic drugs (such as cimetidine, ranitidine, digoxin, and triamterene) that are eliminated by renal tubular secretion may compete for common renal transport systems, resulting in increased plasma concentrations of metformin. Additionally, carbonic anhydrase inhibitors (such as topiramate or acetazolamide) may increase the risk of metabolic acidosis when combined with metformin.

Adverse Reactions

Adverse events associated with metformin predominantly affect the gastrointestinal tract. Common side effects include diarrhea, nausea, vomiting, flatulence, abdominal bloating, and anorexia. Long-term administration has been associated with a decrease in serum vitamin B12 absorption, which may lead to vitamin B12 deficiency or megaloblastic anemia; periodic hematologic monitoring is recommended. Hypoglycemia is rare when metformin is taken alone, but risk increases when co-administered with sulfonylureas or exogenous insulin.

Important Precautions

Metformin carries a Boxed Warning regarding the risk of lactic acidosis, a rare but potentially fatal metabolic emergency characterized by elevated blood lactate levels, metabolic acidosis, and hypothermia. Risk factors include renal impairment, age 65 years or older, radiological studies with contrast, surgical procedures, hypoxic states (such as acute congestive heart failure), severe infection, and excessive alcohol consumption. Assessment of renal function (eGFR) is required prior to initiation: therapy is contraindicated in patients with an eGFR below 30 mL/min/1.73 m², and initiation is not recommended in patients with an eGFR between 30 and 45 mL/min/1.73 m².

What to Avoid While Taking It

Excessive alcohol intake–both acute intoxication and chronic heavy consumption–must be avoided, as alcohol potentiates the effect of metformin on lactate metabolism and increases the risk of severe lactic acidosis. Patients should also avoid sudden severe dehydration, which can impair renal function and elevate metformin levels in the bloodstream.

If You Skip a Dose

If a dose of metformin is missed, it should be taken as soon as remembered with food, unless it is almost time for the next scheduled dose. Patients must not double the dose to make up for a missed tablet, as taking an excessive amount at once increases the likelihood of severe gastrointestinal distress.

Practical Tips

Extended-release formulations must be swallowed whole with liquid and should never be crushed, split, or chewed. Patients taking extended-release tablets may occasionally notice an inactive tablet shell passed in their stool; this is normal and does not indicate a lack of drug absorption. Store the medication at controlled room temperature away from excessive moisture and direct light.

Common Questions

What should be done if an imaging scan requiring contrast dye is scheduled?

Patients must inform their healthcare provider prior to undergoing any radiological procedure involving intravascular iodinated contrast materials. Prescribers typically instruct patients to withhold metformin at the time of or prior to the procedure and resume treatment only 48 hours after the procedure, provided renal function has been re-evaluated and determined to be stable.

Is metformin safe to use during pregnancy?

Metformin crosses the placenta. While clinical data indicate that metformin does not show a clear association with major birth defects, management of gestational diabetes or pre-existing type 2 diabetes during pregnancy requires strict medical supervision. Insulin is traditionally considered the standard of care for glycemic control during pregnancy in the US, so treatment options must be evaluated directly with a prescriber.

Why is routine monitoring of kidney function necessary while taking this drug?

Because metformin is excreted entirely by the kidneys, any impairment in renal filtration leads to accumulation of the drug in the systemic circulation. Elevated serum levels significantly increase the risk of lactic acidosis. Routine blood tests measuring serum creatinine and eGFR allow prescribers to determine if the dose remains safe for the patient.

Can metformin cause low blood sugar levels on its own?

When taken as monotherapy, metformin rarely causes hypoglycemia because it does not stimulate the pancreas to release additional insulin. However, if metformin is combined with other antidiabetic agents, such as insulin or sulfonylureas, the risk of hypoglycemia increases significantly and blood glucose monitoring becomes mandatory.


Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA requirements.

Additional information
Dosage

500mg

,

850mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία